Nathans Famous NATH Steady at 10102 Awaiting Next Catalyst 20260515 Traders Bet Big on Boeing Deal and Tariff Truce Extension as Trump Heads to Beijing Angi ANGI Falls 106 Watching 486 Support 20260519 Guardant Health GH Stalls at 9538 Consolidation Phase 20260519 Gary Stevenson Warns Your Kids Will Be Poorer Than You as US Income Inequality Reaches New Heights Kevin Warsh Faces FOMC Rift Over Rate Cuts as Inflation Pressures Persist Editas Medicine EDIT Q1 2026 Earnings Roar 026 EPS Tops Street View OpenAI Said to Be Preparing for IPO Filing Anthropic Also Eyes Public Listing Report Berkshire Hathaways Stock Sales Signal Shift in Investment Strategy Smart Glasses Market Surge Pressures Traditional Eyewear Leaders The Pitfalls of Chasing High Returns Why Consistency May Matter More Than Performance Jim Cramer Expresses Disappointment Over Toll Brothers Outlook SP 500 and Nasdaq Hold Steady as Investors Eye Mideast Peace Progress Stellantis Restructuring Prediction Market Oversight Oura IPO Lead Morning Market Briefing THO Q1 2026 Earnings Massive EPS Beat Drives Positive Market Response AKTS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development AFGB Q1 2026 Earnings Earnings Miss as Debenture Performance Reflects Subdued Yield Environment CECO Environmental Corp CECO Q1 2026 Earnings EPS Surges Past Estimates with 1395 Surprise Crescent Capital BDC Inc CCAP Q1 2026 Earnings Slight Earnings Miss Amidst Stable Portfolio Performance The Cigna Group CI Downgraded to Hold at Deutsche Bank Amid MultiYear Uncertainty Enbridge Inc ENB Q1 2026 Earnings Earnings Beat Expectations on Strong Operational Performance QMCO Q1 2026 Earnings Adjusted EPS Surprises to the Upside Despite Stock Decline Eagle Point Income Company Inc EIC Q4 2025 Earnings Slight EPS Miss but Stock Holds Steady SCCG Q4 2025 Earnings Significant EPS Beat Despite Stock Decline VKTX Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues RD Investment BANX Q4 2022 Earnings EPS Misses Estimates Amid Market Headwinds AIRO Q4 2025 Earnings EPS Misses Estimates Amid Operational Challenges Capricor Therapeutics Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues to Invest in RD